文献速递妇产影像技术与安全US

个体化列线图在孕早期21三体筛查中的应用

Application of an individualized nomogram in first-trimester screening for trisomy 21.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

该回顾性病例对照研究基于胎儿颈项透明层厚度及超声面部标志物构建列线图,用于孕早期21三体筛查。研究纳入302例21三体妊娠与322例整倍体妊娠,训练集与验证集按约2:1划分。LASSO模型在训练集和验证集的AUC分别为0.983和0.979,均高于基于胎儿NT与孕妇年龄的模型(P<0.001)。

要点

  • 列线图纳入胎儿NT及鼻前厚度/鼻骨长度比等8个面部轮廓标志物,训练集C-index为0.983。
  • LASSO模型在验证集AUC为0.979(95%CI 0.966-0.993),高于基于NT和年龄的模型(P<0.001)。
  • 重测集AUC为0.997(95%CI 0.990-1.000),提示模型稳健性良好。

核心结论

  • 基于胎儿NT和LASSO方法筛选的超声面部轮廓标志物构建的个体化列线图,可能作为孕早期21三体筛查的便捷有效工具。

研究设计与样本

  • 回顾性病例对照研究,纳入302例21三体妊娠和322例整倍体妊娠,按约2:1分为训练集(200例整倍体+200例21三体)和验证集(122例整倍体+102例21三体)。
  • 使用孕11+0至13+6周采集的单胎妊娠二维正中矢状面胎儿轮廓图像,测量12个超声胎儿面部标志物,并记录孕妇年龄、孕龄、胎儿NT及核型。
  • 采用LASSO方法和多变量分析自动筛选判别标志物,建立Logistic回归LASSO模型;从624张图像中随机选取60张作为重测集评估模型稳健性。

关键影像表现/征象

  • LASSO模型纳入8个标志物:胎儿NT、鼻前厚度与鼻骨长度比、面部轮廓线、额上颌面部角、额鼻面部角、下颌上颌面部角、上颌-鼻根-下颌角及d2(前额皮肤前缘至下颌上颌线的距离)(均P<0.05)。

诊断标准与关键数值

  • LASSO模型筛查21三体的AUC在训练集为0.983(95%CI 0.971-0.994),在验证集为0.979(95%CI 0.966-0.993),均高于模型中8个单独超声标志物的AUC。
  • LASSO模型在重测集的AUC为0.997(95%CI 0.990-1.000)。
  • LASSO模型的AUC在训练集和验证集均显著高于基于胎儿NT和孕妇年龄的模型(两者P<0.001)。
  • 列线图的C-index在训练集为0.983,在验证集为0.981。

临床应用与阅片要点

  • 列线图可作为个体化工具预测患者特异性21三体概率,是LASSO模型更直观的呈现方式。
  • 作者认为该列线图可能作为孕早期21三体筛查的便捷有效工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop and validate a nomogram based on fetal nuchal translucency thickness (NT) and ultrasonographic facial markers for screening for trisomy 21 in the first trimester of pregnancy.

METHODS: This was a retrospective case-control study using stored two-dimensional midsagittal fetal profile images captured at 11 + 0 to 13 + 6 weeks' gestation in singleton pregnancies. We included images from 302 trisomy-21 pregnancies and 322 euploid pregnancies. Cases were divided into a training set (200 euploid + 200 with trisomy 21) and a validation set (122 euploid + 102 with trisomy 21) at a ratio of approximately 2:1. For each, the maternal age, gestational age, fetal NT and karyotype were noted, and 12 ultrasonographic fetal facial markers were measured. The least absolute shrinkage and selection operator (LASSO) method and multivariable analysis were used to select automatically the discriminative markers. Logistic regression was used to develop a LASSO model, based on the selected markers, to screen for trisomy 21 in the first trimester of pregnancy. Furthermore, 60 of the 624 images were selected randomly as a retest set to evaluate the model's robustness. The predictive performance of screening for trisomy 21 of a model based on fetal NT and maternal age and of the LASSO model was assessed using the area under the receiver-operating-characteristics curve (AUC). A nomogram was developed as an individualized tool to predict patient-specific probability for trisomy 21, which is a more visual presentation of the LASSO model. The performance of the nomogram was assessed using the C-index and calibration curve.

RESULTS: Into the LASSO model were incorporated eight markers, including fetal NT, prenasal-thickness-to-nasal-bone-length ratio, facial profile line, frontomaxillary facial angle, frontonasal facial angle, mandibulomaxillary facial angle, maxilla-nasion-mandible angle and d2 (distance between the anterior edge of the prefrontal skin and the mandibulomaxillary line) (all P < 0.05). The AUCs of the LASSO model for screening for trisomy 21 were 0.983 (95% CI, 0.971-0.994) in the training set and 0.979 (95% CI, 0.966-0.993) in the validation set, and these were higher than the AUCs of all eight individual ultrasonographic markers included in the model. The AUC of the LASSO model in the retest set was 0.997 (95% CI, 0.990-1.000), indicating good robustness of the LASSO model. The AUC of the LASSO model was significantly higher than that of the model based on fetal NT and maternal age in both training and validation sets (P < 0.001 for both). The nomogram of the LASSO model showed good discrimination of trisomy 21, with C-indices of 0.983 in the training set and 0.981 in the validation set.

CONCLUSIONS: We present an individualized nomogram which incorporates fetal NT and a series of ultrasonographic facial profile markers selected by the LASSO method and multivariable analysis. This nomogram can potentially be utilized as a convenient and effective tool in screening for trisomy 21 in the first trimester of pregnancy. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Sun Y, Zhang L, Dong D, et al. Application of an individualized nomogram in first-trimester screening for trisomy 21. Ultrasound Obstet Gynecol. 2021. PMID: 32438493. doi:10.1002/uog.22087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。